Terns Pharmaceuticals Statistics
Total Valuation
TERN has a market cap or net worth of $2.48 billion. The enterprise value is $2.18 billion.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TERN has 90.08 million shares outstanding. The number of shares has increased by 22.42% in one year.
| Current Share Class | 90.08M |
| Shares Outstanding | 90.08M |
| Shares Change (YoY) | +22.42% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 64.72% |
| Float | 61.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.95 |
| P/TBV Ratio | 8.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.52 |
| Quick Ratio | 19.21 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.12% and return on invested capital (ROIC) is -20.83%.
| Return on Equity (ROE) | -29.12% |
| Return on Assets (ROA) | -19.94% |
| Return on Invested Capital (ROIC) | -20.83% |
| Return on Capital Employed (ROCE) | -37.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.60M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TERN has paid $238,000 in taxes.
| Income Tax | 238,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +346.99% in the last 52 weeks. The beta is -0.24, so TERN's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | +346.99% |
| 50-Day Moving Average | 14.88 |
| 200-Day Moving Average | 7.04 |
| Relative Strength Index (RSI) | 70.62 |
| Average Volume (20 Days) | 3,482,829 |
Short Selling Information
The latest short interest is 9.52 million, so 10.56% of the outstanding shares have been sold short.
| Short Interest | 9.52M |
| Short Previous Month | 10.69M |
| Short % of Shares Out | 10.56% |
| Short % of Float | 15.44% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -108.48M |
| Pretax Income | -94.20M |
| Net Income | -94.44M |
| EBITDA | -108.33M |
| EBIT | -108.48M |
| Earnings Per Share (EPS) | -$1.03 |
Full Income Statement Balance Sheet
The company has $295.64 million in cash and $1.03 million in debt, giving a net cash position of $294.61 million or $3.27 per share.
| Cash & Cash Equivalents | 295.64M |
| Total Debt | 1.03M |
| Net Cash | 294.61M |
| Net Cash Per Share | $3.27 |
| Equity (Book Value) | 284.07M |
| Book Value Per Share | 3.25 |
| Working Capital | 284.91M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -77.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -77.68M |
| FCF Per Share | -$0.86 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TERN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.42% |
| Shareholder Yield | -22.42% |
| Earnings Yield | -3.82% |
| FCF Yield | -3.14% |
Analyst Forecast
The average price target for TERN is $25.59, which is -6.91% lower than the current price. The consensus rating is "Buy".
| Price Target | $25.59 |
| Price Target Difference | -6.91% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -6.12% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |